Deal Announcements

CoDa Therapeutics Starts Second VC Round

Tuesday, April 19, 2011 5:54:00 AM PDT | VentureDeal Staff

San Diego, California  --  Pharmaceutical technology company CoDa Therapeutics has secured the first tranche of its second round of venture capital financing, receiving $19.2 million.

CoDa is developing wound care therapeutics based on gap junction modulation.

Domain Associates, GBS Venture Partners and others made the investment.

The company said it would use the funding to conduct a large Phase 2 multicenter venous leg ulcer trial in the United States and other regions.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin

PCI - Level1